Parenteral Drug Association
 | This article relies largely or entirely on a single source. (November 2019) |
The Parenteral Drug Association (PDA) is an international non-profit industry trade group for pharmaceutical and biopharmaceutical manufacturers.
Founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry, it now has more than 11,000 members worldwide. Today, coordinated through its headquarters and its Training & Research Institute in Bethesda, Maryland, PDA volunteers worldwide promote the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.[1] It has meanwhile opened an office in Berlin and Singapore.
Global Organization
PDA has members in 74 countries and regions:
Africa
Botswana, Egypt, Ghana, South Africa, Tunisia, Zimbabwe
Asia
Bangladesh, China, India, Pakistan
Caribbean, Central, & South America
Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Paraguay
Peru, Uruguay
Europe
Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
Romania, Russia, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland,
Ukraine, United Kingdom
Middle East
Cyprus, Iran, Israel, Jordan, Saudi Arabia, Syria, Turkey, United
Arab Emirates
North America
Canada, Mexico, Puerto Rico, United States
Pacific-Rim
Australia, Hong Kong, Indonesia, Japan,
Malaysia, New Zealand, Singapore, South Korea,
Taiwan, Thailand, Vietnam
References
- ^ "About PDA". Parenteral Drug Association. Retrieved 8 October 2015.